ArticleCancer research and treatment2012
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.
Article in Cancer research and treatment, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 51 citations in OpenAlex.
- Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial.The Lancet. Oncology · 2013Trial
- Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.British journal of cancer · 2013Trial
- Diagnostic and Therapeutic Challenges in the Management of Acute Massive Overt Bleeding of Jejunal Gastrointestinal Stromal Tumours: Case Series.Journal of gastrointestinal cancer · 2023Article
- Imatinib-associated skin rash is related to treatment outcome in patients with unresectable and/or metastatic gastrointestinal stromal tumor.Journal of gastrointestinal oncology · 2022Article
- The Feasibility and Safety of the Clip-and-Snare Method with a Prelooping Technique for Gastric Submucosal Tumors Removal: A Single-Center Experience (with Video).Canadian journal of gastroenterology & hepatology · 2022Article
- Rare Occurrence of Microsatellite Instability in Gastrointestinal Stromal Tumors.Medicina (Kaunas, Lithuania) · 2021Article
- Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study.British journal of cancer · 2020Article
- Diagnosis and Treatment of Duodenal Gastrointestinal Stromal Tumors.Clinical and translational gastroenterology · 2020Article
- A novel technique for removing large gastric subepithelial tumors with ESD method in the subcardia region.Oncology letters · 2019Article
- Life-threatening bleeding with intussusception due to gastrointestinal stromal tumor: a case report.Surgical case reports · 2019Article
- A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST).Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2018Article
- Robotic Gastrotomy With Intracorporeal Suture for Patients With Gastric Gastrointestinal Stromal Tumors Located at Cardia and Subcardiac Region.Surgical laparoscopy, endoscopy & percutaneous techniques · 2018Article
- Small bowel gastrointestinal stromal tumor: a retrospective study of 32 cases at a single center and review of the literature.Therapeutics and clinical risk management · 2018Article
- Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib.Therapeutic advances in medical oncology · 2018Article
- Asian consensus guidelines for gastrointestinal stromal tumor: what is the same and what is different from global guidelines.Translational gastroenterology and hepatology · 2018Review
- Extra-gastrointestinal stromal tumor of the pancreas: report of a case.Annals of hepato-biliary-pancreatic surgery · 2017Article
- Current research and treatment for gastrointestinal stromal tumors.World journal of gastroenterology · 2017Review
- Laparoscopic techniques and strategies for gastrointestinal GISTs.Journal of visualized surgery · 2017Review
- Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.Cancer research and treatment · 2016Article
- Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.Cancer research and treatment · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite their rarity in incidence and prevalence, gastrointestinal stromal tumors (GISTs) have emerged as a distinct and noteworthy pathogenetic entity. The clinical management of GISTs has rapidly evolved due to the recent elucidation of their oncogenic signal transduction pathway and the introduction of molecular-targeted therapies. Successful management of GISTs requires a multidisciplinary approach firmly based on an accurate histopathologic diagnosis. In 2007, the Korean GIST study group published the first guideline for optimal diagnosis and treatment of GISTs in Korea. The second version of the guideline was published in 2010. Herein, we provide the results of relevant clinical studies for the purpose of further revision to the guideline. We expect this new guideline will enhance the accuracy of diagnosis, as performed by members of the Korean associate of physicians involved in GIST patient care, thus improving the efficacy of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.